Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 18478542 | Methods of Treating Cancer with Anti-TIGIT Antibodies | C07K, A61P | Sep 28, 2023 | |
| 18471051 | DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES | A61M, A61K, C07K | Sep 19, 2023 | |
| 18471036 | DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY | C07K, A61K, A61M | Sep 19, 2023 | |
| 18448863 | CYTOTOXIC COMPOUNDS AND CONJUGATES THEREOF | C07K, A61K, A61P | Aug 10, 2023 | |
| 18222313 | IMMUNOMODULATORY ANTIBODY-DRUG CONJUGATES | A61K, A61P, C07H, C07D | Jul 13, 2023 | |
| 18309388 | Combination Therapy | A61P, A61K | Apr 27, 2023 | |
| 18139653 | TREATMENT OF HER2 POSITIVE CANCERS | A61K, A61P | Apr 25, 2023 | |
| 18139592 | SELECTIVE REDUCTION OF PROTEINS | C07K, A61K | Apr 25, 2023 | |
| 18185341 | CAMPTOTHECIN CONJUGATES | A61K, A61P | Mar 15, 2023 | |
| 18062265 | Compositions and Methods for Treating Cancer | A61K, G01N, A61P, C07K | Dec 5, 2022 | |
| 17983970 | DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY | A61M, C07K, A61K | Nov 8, 2022 | Nov 21, 2023 |
| 17979582 | DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES | A61K, A61M, C07K | Nov 1, 2022 | Nov 20, 2023 |
| 17936814 | B7-H4 ANTIBODY-DRUG CONJUGATES FOR THE TREATMENT OF CANCER | A61K, A61P | Sep 28, 2022 | |
| 17734541 | DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY | C07K, A61K, A61M | May 1, 2022 | Nov 8, 2022 |
| 17728350 | DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES | A61K, C07K, A61M | Apr 24, 2022 | Nov 2, 2022 |
| 17697844 | SELECTIVE DRUG RELEASE FROM INTERNALIZED CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS | A61K | Mar 16, 2022 | |
| 17530265 | Treatment of HER2 positive cancers | A61K, A61P | Nov 17, 2021 | Jun 5, 2023 |
| 18030225 | METHODS FOR TREATING CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS | A61P, A61K, G01N | Oct 7, 2021 | |
| 17449074 | HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER | C07K, A61P, A61K | Sep 26, 2021 | Nov 17, 2023 |
| 18025349 | METHODS FOR TREATING CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS | C07K, A61P, A61K | Sep 15, 2021 |